scholarly journals Several studies on the problem of management patients with chronic tonsillitis during periods of remission and exacerbation

2020 ◽  
pp. 109-115
Author(s):  
A. Yu. Ovchinnikov ◽  
N. A. Miroshnichenko ◽  
Yu. O. Nikolaeva ◽  
M. M. Vasilyev
Keyword(s):  
Respiratory Tract ◽  
Randomized Clinical Trials ◽  
Inflammatory Diseases ◽  
Allergic Diseases ◽  
Lymphatic Drainage ◽  
The Body ◽  
Chronic Tonsillitis ◽  
Upper Respiratory Tract ◽  
Bacterial Strains ◽  
Upper Respiratory

Increase in the number of acute and chronic diseases is a global trend. On the one hand, the emergence of new types of viruses, their active mutation, an increase in antibiotic-resistant bacterial strains, a high frequency of immunodeficiency and allergic diseases contribute to this. On the other hand is inadequate treatment of inflammatory diseases of the upper respiratory tract, widespread use of systemic antibiotics without indications. The use of bioregulatory medicines with proven efficacy in the complex treatment can reduce the drug load on the body, reduce the bacterial complications and side effects. Traumeel®S joins the physiological course of inflammation and activates pro-resolving mediators, contributes to its faster completion and tissue repair. The efficacy and safety of Traumeel®S has been confirmed in many randomized clinical trials. The drug has proven its value in almost any inflammatory pathology of the upper respiratory tract and ear. The drug Lymphomyosot®, a multicomponent agent with lymphatic drainage action, has proven itself perfectly in the complex therapy of chronic tonsillitis. In November 2019, the Council of Experts of the National Medical Association of Otorhinolaryngologists on the problems of pathology of the lympharyngeal ring was held. It is recommended to use the multicomponent bioregulatory preparation Traumeel®S to correct the inflammatory process, which has shown in studies a modulating effect on inflammatory mediators without suppressing COX-2 (prostaglandins). With exacerbation of chronic tonsillitis and lymphadenitis of nonspecific etiology, it is possible to use the multicomponent preparation Lymphomyosot®, which helps to improve the drainage and detoxification function of the lymphatic system.

scholarly journals Modern possibilities of herbal medicine in the treatment of acute inflammatory diseases of the upper respiratory tract

2021 ◽  
pp. 127-133
Author(s):  
A. V. Gurov ◽  
A. V. Muzhichkova
Keyword(s):  
Phenolic Compounds ◽  
Respiratory Tract ◽  
Inflammatory Diseases ◽  
The Body ◽  
Upper Respiratory Tract ◽  
Plant Materials ◽  
Pelargonium Sidoides ◽  
Medicinal Substances ◽  
Upper Respiratory ◽  
Tract Infections

The article provides data on the effectiveness of the use of the drug in the treatment of acute, chronic and recurrent diseases of the respiratory tract and ENT organs. The drug is an extract of Pelargonium sidoides. From the standpoint of modern pharmacology, it is known that the use of natural products based on plant materials ensures safety and the absence of pronounced side effects. The main active ingredients of pelargonium are phenolic compounds: coumarins, flavonoids and phenolic acids. The article details the biochemical and pharmacological properties of each of the above groups of compounds. It has been shown that the presence of several classes of phenolic compounds simultaneously contributes to the potentiation of the pharmacological effects of each group separately. Therefore, drug has a pronounced polytropic effect: antiviral, antibacterial, immunomodulatory, mucolytic, anti-inflammatory, antioxidant, cytoprotective. The article presents the results of numerous domestic and foreign randomized, placebo-controlled studies demonstrating its high efficacy and safety in the treatment of ENT diseases, upper respiratory tract infections and bronchitis, not only in adults, but also in children over 1 year old. On the basis of the analyzed and presented material, the authors concluded that the use of a natural-based drug in the treatment of acute respiratory infection is effective and safe, both as monotherapy and in combination with other medicinal substances. He is able to quickly eliminate not only the symptoms of inflammation, but also to support the body with any ailments of this type.

scholarly journals HEMATOLOGICAL AND BACTERIOLOGICAL PREDICTORS OF OCCUPATIONALLY AND INDUSTRIAL CONDITIONED DISEASES IN MEDICAL WORKERS

2020 ◽  
Vol 99 (1) ◽  
pp. 125-128
Author(s):  
L. M. Karamova ◽  
Natalya V. Vlasova ◽  
L. G. Gizatullina ◽  
L. M. Masyagutova
Keyword(s):  
Respiratory Tract ◽  
Allergic Diseases ◽  
The Body ◽  
Hospital Environment ◽  
Upper Respiratory Tract ◽  
Hemoglobin Content ◽  
Hematological Indices ◽  
Mucous Membranes ◽  
Upper Respiratory ◽  
Medical Examinations

Introduction. Medical workers in the process of labor are exposed to a complex of adverse factors: neuro-emotional, physical stress of a chemical, physical and biological nature. A long stay in a hospital environment with medical workers can lead to the formation of various diseases of microbiological etiology or the carriage of pathogenic and conditionally pathogenic flora and the development of dysbiosis. Objective. Give hematological and bacteriological characteristics of the health status of medical workers. Material and methods. The results of laboratory studies of blood and mucous membranes of the upper respiratory tract of medical workers performed during the performing occupational medical examinations are analyzed. Results. Hematological indices were found to be characterized by an increased hemoglobin content in one-fourth of the examined workers, as well as lymphocytosis, eosinophilia, cholesterolemia. The microflora of the mucosa of the upper respiratory tract is mainly represented by Staphylococcus aureus, Candida albicans, Streptococcus pyogenes in 65.2% of the workers; the remaining 34.8% were revealed to have a resident microflora. With the experience of work, the frequency of insemination increases and doubles by 10 years of the work. The structure of microflora is also changing. In the nosological form of occupational morbidity, allergic diseases prevail and account for 60.8%, tuberculosis - 26.0%, and hepatitis - 8,6%. Conclusion. All these changes in the body are the basis of pathogenetic manifestations in the formation of allergic and pathogenic pathologies, which make up to 70.0% of all occupational morbidity.

scholarly journals Using of topical bacterial lysates in modern clinical practice

2021 ◽  
pp. 49-56
Author(s):  
V. M. Svistushkin ◽  
G. N. Nikiforova ◽  
A. V. Zolotova ◽  
V. A. Stepanova
Keyword(s):  
Respiratory Tract ◽  
Inflammatory Diseases ◽  
Human Microbiome ◽  
Allergic Diseases ◽  
The Body ◽  
Economic Consequences ◽  
Medical Community ◽  
Side Reactions ◽  
Upper Respiratory Tract ◽  
Bacterial Lysates

Acute and chronic infectious and inflammatory diseases of the upper respiratory tract occupy a leading position in the structure of the pathology of the world’s population and remain the most frequent reason for patients seeking medical care. The prevalence and frequency of this disease in this nosological group makes a decisive contribution to the structure of the causes of temporary disability, which entails significant negative social and economic consequences. In this aspect, the spread of resistance of pathogens to etiotropic drugs and the insufficient arsenal of pathogenetic drugs stimulate the medical community to search for alternative approaches to the treatment of patients with respiratory pathology. One of these therapeutic areas is the use of immunomodulators, the most commonly used group of which are bacterial lysates. In the modern literature, sufficiently convincing data have been accumulated on the effectiveness of the use of bacterial lysates of systemic action, as a result of which the immune cells of the gastrointestinal tract are activated, which in turn leads to the restoration of autoregulation of the immune response throughout the body, and a decrease in the frequency of infectious and allergic diseases. The latest developments of domestic pharmacologists are topical bacterial lysates, the principle of which is based on the local activation of mucosal immunity in the respiratory tract. The undoubted advantage is that bacterial lysates, with all their effectiveness, do not harm the human microbiome, practically do not cause side reactions, combine well with other drugs, and can also be used at any stage of the disease, including for prophylactic purposes.

scholarly journals Application of mucosecretolytics of plant origin in otorinolaryngology

2021 ◽  
pp. 133-137
Author(s):  
I. Yu. Serebryakova ◽  
T. I. Garashchenko ◽  
A. O. Kuznetsov ◽  
A. O. Akhinyan
Keyword(s):  
Respiratory Tract ◽  
Randomized Clinical Trials ◽  
Inflammatory Diseases ◽  
Antioxidant Properties ◽  
Age Groups ◽  
Herbal Remedies ◽  
Upper Respiratory Tract ◽  
Chronic Inflammatory Diseases ◽  
Laryngeal Mucosa ◽  
Upper Respiratory

In modern otorhinolaryngology the use of herbal remedies, so-called clinical homeopathy, is widely used both as a basic and as part of complex therapy. A special place among this category belongs to medicines with secretolytic and mucolytic properties. This is due to the developed mucociliary system of the mucous membranes of the upper respiratory tract, which primarily suffers in acute and chronic inflammatory diseases. Most chemical mucoactive preparations have only one of the three mucosecretolytic effects and have a large number of contraindications. Herbal preparations, such as those containing Myrtol standardized, have secretolytic and mucolytic properties at the same time. Phytopreparations have deservedly occupied a leading place in the treatment of otorhinolaryngological diseases, as they have practically no contraindications and are successfully used in patients with comorbid pathology, children of all age groups and pregnant women. The efficacy of using preparations containing Myrtol standardized in the treatment of acute and chronic inflammatory diseases of the ENT organs and chronic atrophic diseases of the upper respiratory tract has been studied in a number of randomized clinical trials. The authors analysed 21 literature sources, reflecting the results of using mucosecretolytic drugs in otorhinolaryngology. In the complex treatment of acute rhinosinusitis and rhinopharyngitis the use of natural mucosecretolytic drugs significantly reduces the period of disability and avoids bacterial complications in both adult and paediatric practice. Mucolytic and antioxidant properties of preparations containing Myrtol allow for long-term effective therapy of subatrophic and atrophic processes of pharyngeal and laryngeal mucosa in elderly patients with comorbid pathology. An analysis of randomised trials has proven the efficacy of plant-based mucosecretolytics in the treatment of not only acute but also chronic upper respiratory tract diseases

scholarly journals Species composition of certain strains of microorganisms in the development of upper respiratory tract disease in agricultural workers

2021 ◽  
Vol 100 (11) ◽  
pp. 1261-1266
Author(s):  
Lyaylya M. Masyagutova ◽  
Lilia G. Gizatullina ◽  
Maxmuza K. Gainullina ◽  
Natalya V. Vlasova ◽  
Linara A. Rafikova ◽  
...  
Keyword(s):  
Pseudomonas Aeruginosa ◽  
Respiratory Tract ◽  
Agricultural Production ◽  
Inflammatory Diseases ◽  
The Body ◽  
Antibacterial Drug ◽  
Upper Respiratory Tract ◽  
E Coli ◽  
Leading Role ◽  
Upper Respiratory

Introduction. Microbiocenosis is a self-regulating system of relationships between the body and microflora. Ensuring the technological process of agricultural production involves contact with conditionally pathogenic and pathogenic microflora. The spread of antibacterial drug resistance is a matter of concern. Materials and methods. There was studied the microbiocenosis of the upper respiratory tract in agricultural enterprises: in the absence of inflammatory diseases; the clinical picture of diseases of the ENT organs, and the susceptibility of the isolated strains to antibacterial drugs. Results. Working conditions of employees correspond to classes 3.1 - 3.3. Typical representatives are strains of Streptococcus, Staphylococcus, Micrococcus, Neisseria, Corynebacterium. The etiological share of S. Aureus, C. Albicans, E. Coli, Kl. Pneumoniae, Ps. Aeruginosa, predominates in the formation of inflammatory diseases. Staphylococcus are most susceptible to Cefotaxime and Sparfloxacin, followed by Cefepime, Levofloxacin and Amikacin. Strains of Kl. pneumoniae are susceptible to Cefotaxime and Sparfloxacin; strains of Pseudomonas aeruginosa - to Cefepime and Ceftazidim; C. Albicans and C. crusei - to Amphotericin B and Fluconazole. Conclusion. The complex industrial factors of agricultural production contributes to the violation of the ratio of microbial associations even against the background of clinical health, which is a risk factor for the development of inflammatory processes. S. Aureus strains; Candida Albicans; Klebsiella Pneumoniae play the leading role. Pseudomonas aeruginosa and E. Coli. The isolates demonstrate multidrug resistance to antimicrobial drugs.

scholarly journals A role of oropharyngeal microbiota in developing acute and chronic diseases of the upper respiratory tract

2020 ◽  
Vol 10 (2) ◽  
pp. 359-367
Author(s):  
I. I. Ababii ◽  
L. A. Danilov ◽  
M. K. Maniuc ◽  
P. I. Ababii ◽  
S. S. Ghinda ◽  
...  
Keyword(s):  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Chronic Tonsillitis ◽  
Upper Respiratory Tract Infections ◽  
Control Group ◽  
Healthy Children ◽  
Upper Respiratory Tract ◽  
Upper Respiratory ◽  
Tract Infections

Currently, a rise in incidence of polyethological inflammation of the upper respiratory tract mucosa paralleled by altered resident and transient microbiota displaying in many cases increased antibiotic resistance has been noted. Opportunistic microbes play a major role in developing inflammatory process in Pirogov–Waldeyer’s ring. An inflammatory process occurring in the tonsillar lymphatic tissue results in host systemic complications. Fighting against acute and chronic infections of the upper respiratory tract holds the main task in pediatric otorhinolaryngology, as they can consequently elicit the cardiovascular, genitourinary and musculoskeletal complications. The results of studies examining this issue remain very contradictory, which accounted for a need to conduct our study on the territory of Moldova featured with mixed climatic conditions. Here, we wanted to study a role of microbial factor in etiopathogenesis of chronic tonsillitis in children. Bacteriological microbiota data for superficial palatine tonsils were obtained form 608 children subdivided into 5 groups: group I — 333 children with compensated chronic tonsillitis; group II — 87 children with decompensated chronic tonsillitis; group III — 91 children with acute upper respiratory tract infections (comparison group); group IV — 48 children with acute upper respiratory tract infections treated with antibiotic therapy; group V — 49 apparently healthy children (control group). It was found that β-hemolytic streptococcus exerting high sensitivity to virtually all antibiotics groups was detected in 17.4% of children with acute tonsilar inflammatory processes and decompensated defense in the lymphatic pharyngeal ring compared to 3.5% in control group. Streptococcus pneumoniae was isolated in all study groups ranging within 4.8–21.7%, including 14% in apparently healthy children characterized by reduced antibiotics sensitivity. The data obtained suggest that sickly children with acute and chronic upper respiratory tract infections constitute a risk group for developing somatic diseases. The high incidence of Streptococcus pneumoniae indicates a need for performing immunoprophylaxis, use of therapeutic vaccination as a up-to-date, combined approach in treatment of such pediatric cohort.

scholarly journals 335 The Gut-Lung Axis: The Human Perspective

2020 ◽  
Vol 98 (Supplement_4) ◽  
pp. 69-70
Author(s):  
Michael Surette
Keyword(s):  
Respiratory Tract ◽  
Early Life ◽  
Inflammatory Diseases ◽  
Chronic Inflammatory Disease ◽  
The Body ◽  
Upper Respiratory Tract ◽  
Targeted Interventions ◽  
Susceptibility To Infection ◽  
Airway Diseases ◽  
Asthma And Allergy

Abstract The human gastrointestinal tract is the largest immune organ in the body and consequently influences the overall immune state of all body sites. The gut also harbors the largest proportion of the microbiome. In early life, the maturation of the microbiome and immune system are closely entangled, forming a homeostatic system that imparts individuality and stability to the host microbiome. It is now well established that factors that affect early life gut microbiota modulate susceptibility to chronic inflammatory diseases, including airway diseases such as asthma and allergy. Despite this global influence of the gut on immune response in the lungs, local microbiome-immune interactions also shape the response and susceptibility to disease in the airways. The upper respiratory tract and lung microbiomes also contribute to acute and chronic airway diseases. Modulating the gut-lung axis as well as respiratory tract through microbiome-targeted interventions to promote health and reduce susceptibility to infection and chronic inflammatory disease may represent an effective strategy, particularly in early and late life.

scholarly journals New prospects for local etiotropic treatment of acute respiratory viral infections

2019 ◽  
pp. 105-108
Author(s):  
A. A. Krivopalov ◽  
V. A. Shatalov ◽  
S. V. Shervashidze
Keyword(s):  
Respiratory Tract ◽  
Respiratory System ◽  
Safety Profile ◽  
Viral Infections ◽  
Inflammatory Diseases ◽  
Upper Respiratory Tract ◽  
Positive Experience ◽  
High Efficacy ◽  
Upper Respiratory ◽  
Respiratory Viral Infections

According to WHO, the respiratory system diseases are currently inside the ten most common pathologies. The modern strategy for treating influenza and ARVI gives priority to the antiviral and immunostimulating agents, but the symptomatic drugs, which include preparations based on silver and its compounds, also play an important role. The large positive experience in using silver preparations supported by numerous clinical studies shows their high efficacy and satisfactory safety profile in the treatment of infectious and inflammatory diseases of the nose and upper respiratory tract in children and adults.

The Role of Bacterial Interference in Otitis, Sinusitis and Tonsillitis

2005 ◽  
Vol 133 (1) ◽  
pp. 139-146 ◽  
Author(s):  
Itzhak Brook
Keyword(s):  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Antimicrobial Agents ◽  
Bacterial Flora ◽  
Upper Respiratory Tract ◽  
Bacterial Strains ◽  
Upper Respiratory ◽  
Tract Infections ◽  
Bacterial Interference

Bacterial interactions that include antagonism (interference) and synergism help maintain balance between the members of the normal endogenous flora. Alpha-streptococci that predominate in the normal respiratory tract flora attracted most attention in studies of bacterial interference. Other organisms that possess interfering characteristics in upper respiratory tract infections (URTIs) are nonhemolytic streptococci, and Prevotella and Peptostreptococcus spp. The production of bacteriocins by some microorganisms is one of the important mechanisms of interference. The role of bacterial interference in the development of URTI and its effect on the eradication of these infections is discussed. These infections include pharyngo-tonsillitis, otitis media, and sinusitis. Treatment with various antimicrobial agents can affect the balance between members of the oro-pharyngeal bacterial flora and interfering organisms. Implantation into the indigenous microflora of low virulence bacterial strains that are potentially capable of interfering with colonization and infection with other more virulent organisms has been used in preliminary studies as a means of coping with the failure of antimicrobials in the treatment of several URTI.

Sign in / Sign up

Export Citation Format

Share Document